Performing a cost-effectiveness analysis (CEA) is a crucial part of the decision-making process for any imaging provider. The industry lacks consistency when it comes to exactly how CEAs are carried out, however, which can make their conclusions less reliable.

A patient at Lowell General Hospital’s Saints Campus in Massachusetts suffered a fractured facial bone after a hamper containing metal flew across the room during the man’s MRI procedure, the Lowell Sun reported.

The FDA approved the FreeStyle Libre flash glucose monitoring system, which works for up to 14 days at a time, according to an announcement from device maker Abbott.

Community-based academic radiologists—hybrid practitioners who focus on both academia and community health—could be key in improving access to specialized care, two University of Texas researchers report in the current edition of the Journal of the American College of Radiology.

A 28-year-old nightclub employee in Singapore has been fined and sentenced to 41 months in prison for impersonating a breast cancer screening service employee to get women to send him photos of themselves.

Fujifilm’s Aspire Cristalle breast imaging system violates four patents owned by Hologic, according to the initial ruling on July 26 of U.S. International Trade Commission Judge Clark Cheney.

Women who opt for digital breast tomosynthesis (DBT) over mammography alone are likely to see lower recall rates, improved quality measures and shorter times to biopsy, researchers reported in Academic Radiology this month.

Jeff Immelt, former CEO of General Electric, announced on LinkedIn that he will be advising Collective Health, a start-up that offers software-driven workforce health management systems. The move comes less than a year since he announced his retirement as president and director of GE’s board and less than six months after becoming chairman of Athenahealth.